Breaking the Speed–Risk Trade-off in Genomic Medicine

Genomic medicine promises transformative treatments, but progress has often been slowed by complexity, uncertainty, and risk. What if accelerating innovation and reducing risk were not opposing forces? This session looks at how the trade-off can be overcome from a CMC perspective. We will explore levers like molecule optimization, flexible platforms, and commercially ready facilities that make tech-transfers obsolete.